Manjula Shenoy K

Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients

Balaswamy Reddy, V. Lokesh, M. S. Vidyasagar et al. · Oral Oncology · 2014 · 109 citations

Medicine, Oncology, Pharmacotherapy +6

Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients.

Steven Friedman, Richard Levy, William M. Garrett et al. · Cancer Research · 2009 · 37 citations

Medicine, Oncology, Pharmacology +17

An open-label, randomized, study of h-R3mAb (nimotuzumab) in patients with advanced (stage III or IVa) squamous cell carcinoma of head and neck (SCCHN): Four-year survival results from a phase IIb study.

K. Govind Babu, Lokesh Viswanath, Balaswamy Reddy et al. · Journal of Clinical Oncology · 2010 · 37 citations

Medicine, Oncology, Radiation Oncology +16

A Novel Framework for the Generation of Multiple Choice Question Stems Using Semantic and Machine-Learning Techniques

Archana Praveen Kumar, Ashalatha Nayak, Manjula Shenoy K et al. · International Journal of Artificial Intelligence in Education · 2023 · 37 citations · Full text

Computing, Computer Science, Educational Assessment +14

A New Similarity measure for taxonomy based on edge counting

Manjula Shenoy K · International journal of Web & Semantic Technology · 2012 · 29 citations · Full text

Computing, Computer Science, Computational Linguistics +14